![]() |
|
Lab21 on acquisition trail
Lab21, a Cambridge-based healthcare diagnostics company, has acquired Plasmatec Laboratory Products, a Dorset-based manufacturer and distributor of in vitro diagnostic tests.
The deal comes shortly after the acquisition of Biotec Laboratories. Graham Mullis, CEO of Lab21, commented: “Plasmatec will continue to be based in Dorset but there will be significant cross-selling opportunities within Lab21’s enlarged diagnostic products division. This acquisition follows the purchase earlier this year of Biotec Laboratories Ltd and underlines the momentum of our buy-and-build strategy.”
Martin Shaw, founder and managing director of Plasmatec, said: “Plasmatec is well placed to add to Lab21’s growing product portfolio and offers particular expertise in the Middle East and South American markets.”

People also read ... |
Related Articles |
Useful links
M&A News
- Alterian's Intrepid acquisition Sep 01 2010
- Dwell unlocks £5 million funding Aug 31 2010
- Moonfruit raises expansion funds Aug 31 2010
- Compass acquires Vision Security Group Aug 31 2010
- BGC Partners buys Mint Aug 25 2010
